1. Lopez, AD, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367: 1747–1757.
2. WHO. Progress in reducing global measles deaths: 1999–2004. Weekly Epidemiological Record 2006; 81: 90–94.
3. CDC. Global Measles and Rubella Laboratory Network, January 2004–June 2005. Morbidity and Mortality Weekly Report 2005; 54: 1100–1104.
4. Slater, PE. Measles containment in Israel. Israel Journal of Medical Sciences 1991; 27: 19–21.
5. Slater, PE, Anis, E, Leventhal, A. Measles control in Israel: a decade of the two-dose policy. Public Health Reviews 1999; 27: 235–241.
6. Ministry of Health Israel. Public Health Services, Department of Epidemiology. In: Report on Routine Childhood Immunization Schedule Coverage in Israel 2002: MMR vaccine. Jerusalem, Israel, 2005.
7. WHO. Guidelines for Epidemic Preparedness and Response to Measles Outbreaks. May 1999. Geneva: World Health Organization.
8. Yip, FY, Papania, MJ, Redd, SB. Measles outbreak epidemiology in the United States, 1993–2001. Journal of Infectious Diseases 2004; 189 (Suppl. 1): S54–60.
9. Muscat, M, Glismann, S, Bang, H. Measles in Europe in 2001–2002. Eurosurveillance 2003; 8: 123–129.
10. Riddell, MA, Rota, JS, Rota, PA. Review of the temporal and geographical distribution of measles virus genotypes in the pre-vaccine and post-vaccine eras. Virology Journal 2005; 2: 87.
11. WHO. New genotype of measles virus and update on global distribution of measles genotypes. Weekly Epidemiological Record 2005; 80: 347–351.
12. CDC. Case definitions for infectious conditions under public health surveillance. Morbidity and Mortality Weekly Report. Recommendations and Reports 1997; 46: 17–18.
13. WHO. Expanded Programme on Immunization (EPI). Standardization of the nomenclature for describing the genetic characteristics of wild-type measles viruses. Weekly Epidemiological Record 1998; 73: 265–269.
14. WHO. Update of the nomenclature for describing the genetic characteristics of wild-type measles viruses: new genotypes and reference strains. Weekly Epidemiological Record 2003; 78: 229–232.
15. Choshen, M (ed.) Population of Israel and Jerusalem by population group, 2002–2003. In: Statistical Yearbook of Jerusalem No. 20–2002/2003. Jerusalem, 2004, pp. 258–259.
16. McBrien, J, et al. Measles outbreak in Dublin, 2000. Paediatric Infectious Disease Journal 2003; 22: 580–584.
17. Coughlan, S, et al. Suboptimal measles-mumps-rubella vaccination coverage facilitates an imported measles outbreak in Ireland. Clinical Infectious Diseases 2002; 35: 84–86.
18. Van den Hof, S, et al. Measles outbreak in a community with very low vaccine coverage, the Netherlands. Emerging Infectious Diseases 2001; 7 (3 Suppl.): 593–597.
19. Siedler, A, et al. Two outbreaks of measles in Germany 2005. Eurosurveillance 2006; 11: 131–134.
20. Spika, JS, et al. Measles outbreak in the Ukraine, 2005–2006. Eurosurveillance Weekly Release 2006; 11(3).
21. García-Comas, L. Measles outbreak in the region of Madrid, Spain, 2006. Eurosurveillance Weekly Release 2006; 11(3).
22. Muscat, M, et al. Measles outbreak in the Øresund region of Denmark and Sweden. Eurosurveillance Weekly Release 2006; 11(3).
23. CDC. Import-associated measles outbreak – Indiana, May–June 2005. Morbidity and Mortality Weekly Report 2005; 54: 1073–1075.
24. CDC. Measles – United States, 2004. Morbidity and Mortality Weekly Report 2005; 54: 1229–1231.
25. Rooney, JA, et al. The largest outbreak of measles in the United States during 1999: imported measles and pockets of susceptibility. Journal of Infectious Diseases 2004; 189 (Suppl. 1): S78–80.
26. Mulholland, EK. Measles in the United States, 2006. New England Journal of Medicine 2006; 355: 440–443.
27. Parker, AA, et al. Implications of a 2005 Measles Outbreak in Indiana for Sustained Elimination of Measles in the United States. New England Journal of Medicine 2006; 355: 447–455.
28. Richard, JL, Zimmermann, H. Recent increase in measles in children and teenagers in Switzerland. Eurosurveillance Weekly Release 2003; 7 (23).
29. Wright, JA, Polack, C. Understanding variation in measles-mumps-rubella immunization coverage – a population-based study. European Journal of Public Health 2006; 16: 137–142.
30. Hutchins, SS, et al. Vaccination levels associated with lack of measles transmission among preschool-aged populations in the United States, 1989–1991. Journal of Infectious Diseases 2004; 189 (Suppl. 1): S108–115.
31. Meissner, HC, Strebel, PM, Orenstein, WA. Measles vaccines and the potential for worldwide eradication of measles. Pediatrics 2004; 114: 1065–1069.
32. Nagaraj, A. Does qualitative synthesis of anecdotal evidence with that from scientific research help in understanding public health issues: a review of low MMR uptake. European Journal of public health 2006; 16: 85–88.
33. Agur, Z, et al. Measles immunization strategies for an epidemiologically heterogeneous population: the Israeli case study. Proceedings of the Royal Society of London, Series B: Biological Sciences 1993; 252: 81–84.
34. Tulchinsky, TH, et al. Measles during the Gulf War: a public health threat in Israel, the West Bank, and Gaza. Public Health Reviews 1992–93; 20: 285–296.
35. Belmaker, I, et al. Reduction of vaccine-preventable communicable diseases in a Bedouin population: summary of a community-based intervention programme. Lancet 2006; 367: 987–991.
36. Hanratty, B, et al. Measles outbreak in non-immune anthroposophic communities: the implications for the elimination of measles from Europe. Epidemiology and Infection 2000; 125: 377–383.
37. Grais, RF, et al. Exploring the time to intervene with a reactive mass vaccination campaign in measles epidemics. Epidemiology and Infection 2006; 134: 845–849.